GAIN THERAPEUTICS INC

Ticker: GANX CUSIP: 36269B105 Class: COM

VANGUARD GROUP INC's Holding History (CIK: 0000102909)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 569,901 Value ($000) $1,835 Avg Close $2.67 Range $1.66 - $4.34
Q3 2025
Shares 534,352 Value ($000) $946 Avg Close $1.69 Range $1.41 - $2.12
Q2 2025
Shares 534,352 Value ($000) $962 Avg Close $1.85 Range $1.48 - $2.27
Q1 2025
Shares 254,990 Value ($000) $487 Avg Close $2.22 Range $1.54 - $2.81
Q4 2024
Shares 177,075 Value ($000) $382 Avg Close $2.01 Range $1.50 - $3.19
Q3 2024
Shares 145,217 Value ($000) $258 Avg Close $1.26 Range $0.89 - $2.00
Q2 2024
Shares 145,217 Value ($000) $186 Avg Close $2.60 Range $1.20 - $4.04
Q1 2024
Shares 119,364 Value ($000) $450 Avg Close $4.15 Range $3.17 - $5.33
Q4 2023
Shares 88,385 Value ($000) $289 Avg Close $2.78 Range $2.00 - $3.49
Q3 2023
Shares 70,280 Value ($000) $231 Avg Close $3.79 Range $3.03 - $4.78
Q2 2023
Shares 64,118 Value ($000) $287 Avg Close $4.88 Range $4.25 - $6.19
Q1 2023
Shares 52,605 Value ($000) $254 Avg Close $4.09 Range $3.15 - $5.25